SlideShare a Scribd company logo
Nuclear QA: Case
     Review
     Darcy Conaway
      January 2010
OUTLINE

ā€¢ CASES FROM AUGUST, SEPTEMBER, AND
  OCTOBER 2009
ā€¢ TRENDS
ā€¢ DISCUSSION OF WAYS TO IMPROVE
  REPORTING
About Nuclear QA
ā€¢ Keepcath of all patients that had a nuclear followed
  by a
       log
           within a year
  ā€¢ Do the ļ¬ndings correlate?
   ā€¢ COMPLETE AGREEMENT
   ā€¢ GENERAL AGREEMENT
   ā€¢ MINOR DISCORDANCE
   ā€¢ MAJOR DISCORDANCE
Nuke QA Started in 2008

ā€¢ Initial problems primarily due to very high false
  positive rate causing high major discordance rates
ā€¢ We initiated prone imaging, using regadenoson,
  became diligent with patient selection (ex: 2-day
  studies for elevated BMI) and adopted the ASNC
  recommended method for reporting
ā€¢ 2009 trends showed improvement
**Signiļ¬cant percentages of major
 discordances when comparing nuclear to
          cardiac catheterization
  --July 2008: 5 major discordances (71%)
               7 total for correlation
--August 2008: 1 major discordance (20%)
                5 total for correlation
 --September 2008: 3 major discordances
                    (50%)
               6 total for correlation
-cont.
October 2008: 5 major discordances (36%)

 
   
       
   14 total for correlation
November 2008: No major discordances
 (0%)

 
   
       
   14 total for correlation


December 2008: 1 major discordance (17%)

 
   
       
   6 total for correlation
Trends January 2009-May 2009


 ā€¢ January 2009: No major discordances (4 total for
correlationļƒ 0%
 ā€¢ February 2009: 2 major discordances (8 total for
 review; 1 of these was deemed appropriately read and due
to quality of imaging by case review)ļƒ 13%
 ā€¢   March 2009: No nuclear/cath for correlation
 ā€¢   April 2009: 0 major discordance (5 total for
reviewļƒ 0%)
 ā€¢   May 2009: 1 major discordance that is due to patchy
uptake in a cardiomyopathy patient (4 total for correlation)
 ā€¢   June 2009: No major discordances
 ā€¢   July 2009: 1/6 major discordance (17%)
Trends and Case Review
          8/09-10/09


ā€¢ AUGUST 2009: 78 total nukes done
ā€¢ 3 for correlation with cath
ā€¢ 1 major discordanceā€¦.WOULD LIKE
  INPUT AS TO WHETHER OR NOT THIS IS
  A MAJOR DISCORDANCE
ā€¢   MPI 2/3/09           CASE 1
ā€¢   CATH 8/28/09

ā€¢   1-DAY STUDY

ā€¢   REGADENOSON

ā€¢   PRONE USED AS AN
    ADJUNCT

ā€¢   ECG NEGATIVE

ā€¢   POST STRESS
    IMAGING 45 MINUTES
    AFTER INJECTION
SHORT AXIS SUPINE   SHORT AXIS PRONE
LONG AXIS SUPINE   LONG AXIS PRONE
POLARMAPS
REMINDER: PRONE
MPI IMPRESSION




ā€¢ NEGATIVE ECG FOR ISCHEMIA
ā€¢ NORMAL EF
ā€¢ NORMAL PERFUSION
CATH

ā€¢ LM normal
ā€¢ LAD 40% proximal, 40-50% mid to distal
ā€¢ diag 2 30%
ā€¢ LCx 70% distally, small artery
ā€¢ RCA (dominant) subtotal occlusion proximal with left
  to right collaterals
 ā€¢ unsuccessful angioplasty; small self contained
    coronary perforation
NUKE MISREAD OR MISSED ISCHEMIA?
ā€¢   LABELLED AS A FALSE NEGATIVE BUT I THINK THIS
    IS LIKELY A MINOR DISCORDANCE

    ā€¢   DISTAL LCX IS SMALL; MAY BE MILDLY ISCHEMIC
        BUT THE QUALITY OF THE REST IMAGES ARE
        PROBLEMATIC IN READING THIS STUDY
        ACCURATELY

ā€¢   COLLATERALS TO THE RCA WOULD PREVENT IT
    FROM BEING ISCHEMIC AND ECG WAS NEGATIVE

    ā€¢   ONE POINT: SHOULD ATTEMPT PRONE OF REST
        WHEN DEFECT PRESENT

    ā€¢   CONCERN: DID WE PERFORM PROCEDURE
        CORRECTLY/I.E. MAXIMAL HYPEREMIA WITH
        REGADENOSON? ECG NEGATIVE ...
                          FALSE NEGATIVE? MINOR DISCORDANCE?
                            NOT GETTING MAXIMAL HYPEREMIA
                                  WITH REGADENOSON?
CORRELATION


ā€¢ SEPTEMBER (N=85)
 ā€¢ 12 FOR CORRELATION; 1 EXCLUDED
   DUE TO BEING >1 YEAR FROM NUKE
   TO CATH
 ā€¢ 1 MAJOR DISCORDANCE THAT WAS
   LIKELY BALANCED ISCHEMIA
   (ā€˜ACCEPTABLE FALSE NEGATIVEā€™)
-CONT




ā€¢ OCTOBER (N=60); 11 TO CORRELATE
ā€¢ 8/11 WERE CA OR GA
 ā€¢ 13 TOTAL: 1 NON-DIAGNOSTIC, 1
   EXCLUDED DUE TO BEING JUST AT A
   YEAR OUT FROM CATH
 ā€¢ 2 MINOR DISCORDANCES
 ā€¢ 1 UNKNOWN: MPI NO ISCHEMIA;
   CATH WITH LAD BRIDGING.
   GENERAL AGREE?
CASE 2: SHORT AXIS SUPINE
ā€¢   MPI 8/4/09

ā€¢   ONE DAY STUDY

ā€¢   REGADENOSON

ā€¢   PRONE USED AS AN
    ADJUNCT

ā€¢   NEGATIVE ECG

ā€¢   STRESS IMAGING 48MIN
    AFTER ISOTOPE

ā€¢   REST IMAGING 45 MIN
    AFTER
SHORT AXIS SUPINE   SHORT AXIS PRONE
LONG AXIS SUPINE   LONG AXIS PRONE
MPI IMPRESSION


ā€¢ MILDLY ABNORMAL (SSS6) WITH FIXED
  INFERIOR/INFEROLATERAL DEFECT
ā€¢ QUALITY:FAIR
ā€¢ EF NORMAL WITH MILD INFERIOR/
  INFEROLATERAL HYPOKINESIS
CATH

ā€¢ LM normal
ā€¢ LAD ostial 60%
ā€¢ LCx free of disease
ā€¢ RCA free of disease
ā€¢ Ramus free of disease
CASE OF SIGNIFICANT ARTIFACT
    THAT LED TO MISREAD
   PLANAR: ELEVATED LEFT       MINOR
      HEMIDIAPHRAGM        DISCORDANCE?
        FAIR QUALITY
CASE 3

ā€¢   2-DAY STUDY

ā€¢   EXERCISE (6:32)

ā€¢   MALE PT

ā€¢   STRESS IMAGING 2
    HOURS AFTER
    INJECTION; REST
    IMAGING 40 MINUTES
    AFTER INJECTION
SHORT AXIS SUPINE   SHORT AXIS PRONE
LONG AXIS SUPINE   LONG AXIS PRONE
POLARMAPS
REVIEW: PRONE
MPI IMPRESSION



ā€¢ MILDLY ABNORMAL; SUGGESTIVE OF
 BRANCH VESSEL LAD DISEASE
 (DIAGONAL)
ā€¢ TECHNICAL ISSUES WITH GATING SO
 NO EF GIVEN
CATH




ā€¢ NORMAL CORONARIES
ā€¢ MPI PLANAR WITH MILD BREAST
 ATTENUATION, LATERAL WALL FAT
 AND MILD VERTICAL MOTION
                MINOR DISCORDANCE?
                 MORE SIGNIFICANT?
CASE 4
ā€¢   1-DAY STUDY

ā€¢   REGADENOSON

ā€¢   PRONE USED AS AN
    ADJUNCT

ā€¢   REST: 1HR AND 15 MIN
    AFTER INJECTION

ā€¢   STRESS:1 HOUR AND 5
    MINUTES AFTER
SHORT AXIS SUPINE   SHORT AXIS PRONE
LONG AXIS SUPINE   LONG AXIS PRONE
POLARMAPS
MPI IMPRESSION



ā€¢ OCCLUDED LCX AND/OR RCA
 BRANCH VESSEL AT BASE WITHOUT
 ISCHEMIA
ā€¢ LOW RISK
ā€¢ MILDLY REDUCED EF
CATH




ā€¢ NON OBSTRUCTIVE CAD
               THIS IS DOWN AS A
              GENERAL AGREEMENT
             SINCE IT WAS READ AS
             LOW RISK; CHANGE TO
                DISCORDANCE?
NEXT CASE


ā€¢   45 Y/O MALE WITH KNOWN CAD/PRIOR MI

ā€¢   EXERCISE STUDY (7:46)

ā€¢   ECG WITH T WAVE INVERSION AT BASELINE
    INFEROLATERALLY; PSEUDONORMALIZATION
    DURING STRESS

ā€¢ 1-DAY STUDY WITH PRONE AS
    ADJUNCT
CASE 5
SUPINE            PRONE
MPI
                IMPRESSION
ā€¢   ABNORMAL WITH LARGE FIXED INFERIOR
    DEFECT AND MODERATE FIXED ANTERIOR
    DEFECT
    ā€¢   DO YOU AGREE ? THOUGHTS....
ā€¢   NORMAL EF
ā€¢   POOR QUALITY
ā€¢   Prior nuke in 2003 with large defect, also non-
CATH-the plot thickens


ā€¢ The one we correlated with was 10/09:
 ā€¢ No signiļ¬cant CAD; mid-distal focal area
    of myocardial bridging LAD
ā€¢ Prior cath in 2005:
 ā€¢ 90% proximal ramus intermedius
 ā€¢ 50-60% proximal rca
                           SO IS THIS THE
                           WRONG CATH?
NEXT CASE: GOOD
   CORRELATION DESPITE
      ATTENUATION

ā€¢ 39 Y/O FEMALE
ā€¢ 2-DAY STUDY DUE TO BMI
ā€¢ REGADENOSON (??)
ā€¢ SEVERE BREAST ATTENUATION
ā€¢ PRONE USED AS ADJUNCT
 ā€¢ SHOULD WE HAVE DONE NUKE?
CASE 6
SHORT AXIS            SHORT AXIS
  SUPINE                PRONE
LONG AXIS
            LONG AXIS PRONE
SUPINE
POLARMAPS
MPI IMPRESSION



ā€¢ POOR QUALITY: SEVERE BREAST
  ATTENUATION
ā€¢ MODERATE AREA OF INFARCTION
  INFERIOR AND INFEROLATERALLY
  SUGGESTING RCA AND/OR LCX
  DISEASE
ā€¢ NORMAL EF
CATH




ā€¢ TWO VESSEL CAD
 ā€¢ RCA MID 90%, MID-DISTAL 70%
 ā€¢ MID LAD 60% (NEGATIVE FFR OF LAD)
NEXT CASE



ā€¢ 56Y/O MALE WITH PPM
ā€¢ REGADENOSON
ā€¢ 1-DAY STUDY WITH PRONE AS
 ADJUNCT
SHORT AXIS SUPINE   SHORT AXIS PRONE
potter 2
MPI IMPRESSION AND CATH


ā€¢ MPI: RCA OR LCX INFARCTION WITH
  MINIMAL RESIDUAL ISCHEMIA ; LOW
  RISK
ā€¢ CATH: 3 VESSEL CAD
 ā€¢ 70-80% PROX LAD, 99% OSTIAL LCX,
   80% MID RCA   LIKELY A CASE OF BALANCED
                 ISCHEMIA WITH TIGHTER LCX SO
                 ONLY ONE DISTRIBUTION
                 DEMONSTRATED ISCHEMIA; MAJOR
                 DISCORDANCE THAT IS
                 ā€œACCEPTABLE?ā€
NEXT CASE

ā€¢ 58Y/O FEMALE
ā€¢ EXERCISE STUDY (6:20)
ā€¢ 1-STUDY STUDY
ā€¢ PLANAR FINDINGS NOT MENTIONED-
 QUALITY LISTED AS FAIR (LIKELY
 BREAST ATTENUATION)
ā€¢ PRONE USED AS ADJUNCT
SHORT AXIS SUPINE   SHORT AXIS PRONE
wright 5
CORRELATION



ā€¢   MPI: ABNORMAL; POSITIVE FOR ISCHEMIA

ā€¢   NO MENTION OF RISK OF STUDY

ā€¢   ANTERIOR DEFECT FELT TO BE DUE TO BREAST;
    MODERATE REVERSIBLE DEFECT APICALLY AND LATERALLY

ā€¢   CATH: LAD PCI; MILD TO MODERATE LCX (NO
    PERCENTAGE GIVEN), PLV OSTIUM (SMALL VESSEL) WITH
    90% FOCAL STENOSIS

       FOR QA: GENERAL AGREE? SOME COMMENT SHOULD BE MADE
       THAT NUKE NOT GOOD FOR THIS PT IN THE FUTURE DUE TO
       SEVERITY OF BREAST ATTENUATION? PLACE IT INTO NON-
       DIAGNOSTIC FOR LAD TERRITORY?
NOVEMBER/DECEMBER


ā€¢ HIGH NUMBERS OF POOR QUALITY STUDIES
ā€¢ NOVEMBER: (N=80);14 FOR CORRELATION
 ā€¢   7/14 WERE IN GENERAL OR COMPLETE AGREEMENT

 ā€¢   2 MINOR DISCORDANCE-->PLANAR FINDINGS NOT DESCRIBED ON EITHER OF
     THESE

 ā€¢   3 MAJOR DISCORDANCE--> 1 LIKELY BALANCED ISCHEMIA (ā€˜ACCEPTABLEā€™ MAJOR
     DISCORDANCE); ANOTHER DESCRIBED AS POOR QUALITY BUT NOT READ AS
     NON-DIAGNOSTIC; OTHER NEEDS REVIEW

 ā€¢   1 NON-DIAGNOSTIC DUE TO BREAST ATTENUATION

 ā€¢   ISSUE: IF POOR QUALITY STUDY WE SHOULD STATE WHY IN PLANAR SECTION AND
     READ STUDY AS NON-DIAGNOSTIC
ā€¢ DECEMBER (N=59); 14 FOR CORRELATION
 ā€¢ 7/14 CA OR GA
 ā€¢ I MINOR DISCORDANCE
 ā€¢ 2 MAJOR DISCORDANCE; 1 DOCUMENTED AS
   POOR QUALITY STUDY

 ā€¢ 1 READ AS NON-DIAGNOSTIC DUE TO BREAST,
   1 READ AS EQUIVOCAL DUE TO SEVERE
   VERTICAL MOTION, 1 TECHNICAL ISSUE (FAIR
REPORTING ISSUES
ā€¢ MANY STUDIES WITHOUT MENTION OF
 PLANAR IMAGING FINDINGS
ā€¢ NEED TO STATE IF PRONE WAS OR WAS NOT
 PERFORMED
ā€¢ MUST HAVE CORONARY ARTERY DISTRIBUTION
 FOR DEFECTS--MANY STUDIES REPORTED ONLY
 AS ISCHEMIC WITHOUT MENTION OF
 DISTRIBUTION OR SEVERITY OF RISK (MILD/
 MOD/SEVERE)
REVIEW
ā€¢ OVERALL TREND FOR 2009 WAS
  SIGNIFICANT IMPROVEMENT
ā€¢ THE LAST TWO MONTHS THERE WERE
  INCREASED NUMBERS OF POOR
  QUALITY IMAGES (PT SELECTION?)
ā€¢ PHYSICIAN REPORTS: LACKING
  PLANAR IMAGING FINDINGS AND
  CONSISTENCY IN TERMS OF STATING
  RISK
REMINDER: ASNC GUIDELINES
        FOR REPORTING

ā€¢ REQUIRED: PERFUSION DEFECT LOCATION,
 SEVERITY, AND SIZE
 ā€¢ SEVERITY= MILD,MODERATE,SEVERE
 ā€¢ SMALL= 1-2 SEGMENTS
 ā€¢ MEDIUM=3-4 SEGMENTS
 ā€¢ LARGE= 5 OR MORE SEGMENTS
 ā€¢ TID IS REQUIRED
TO THINK ABOUT...
ā€¢ MANY EXPERTS BELIEVE THAT AC IMAGING CAN
  INCREASE THE NUMBER OF STRESS ONLY
  IMAGES (GETTING ASKED MORE FREQUENTLY
  TO DO THIS WHEN POSSIBLE ON IN-PTS)
ā€¢ REMINDER: THIS IS APPLICABLE MAINLY TO PTS
  WHO EXERCISE
 ā€¢ PHARMACOLOGIC NORMALS HAVE
   SIGNIFICANTLY HIGHER RATE OF CARDIAC
   EVENTS WITHIN THE NEXT YEAR AS
   COMPARED TO NORMALS WHO DID BRUCE

More Related Content

Similar to Nuke Qa Case Review 2010 Ppt

Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
IACTSWeb
Ā 
Localised carcinoma prostate.pptx
Localised carcinoma prostate.pptxLocalised carcinoma prostate.pptx
Localised carcinoma prostate.pptx
DrYashSharma
Ā 
Us The Surgeon New Best Companion
Us The Surgeon New Best CompanionUs The Surgeon New Best Companion
Us The Surgeon New Best Companion
u.surgery
Ā 
Management of sepsis.
Management of sepsis.Management of sepsis.
Management of sepsis.
MEEQAT HOSPITAL
Ā 
Electrodiagnosis of GBS
Electrodiagnosis of GBSElectrodiagnosis of GBS
Electrodiagnosis of GBS
Dr. Arun Mathai Mani
Ā 
RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)
RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)
RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)
DrAnkitaPatel
Ā 
Principles of nuclear cardiology
Principles of nuclear cardiologyPrinciples of nuclear cardiology
Principles of nuclear cardiology
Hiralal Pawar
Ā 
MANAGEMENT OF TRAUMA
MANAGEMENT OF TRAUMAMANAGEMENT OF TRAUMA
MANAGEMENT OF TRAUMA
annaselvabai
Ā 
Shoulder advances 2015
Shoulder advances  2015Shoulder advances  2015
Shoulder advances 2015
Lennard Funk
Ā 
Inflammatory arthritis; a quick run through.
Inflammatory arthritis; a quick run through.Inflammatory arthritis; a quick run through.
Inflammatory arthritis; a quick run through.
Ronan Kavanagh
Ā 
ACS:STEMI
ACS:STEMIACS:STEMI
ACS:STEMI
SourabHiremath
Ā 
Contrast nephropahthy
Contrast nephropahthyContrast nephropahthy
Contrast nephropahthy
Mohammed Alsheikh
Ā 
ANA Negative Lupus
ANA Negative Lupus ANA Negative Lupus
ANA Negative Lupus
Jerriton Brewin
Ā 
Inquisito-AIIMS Medicine Quiz 2021 - Prelims
Inquisito-AIIMS Medicine Quiz 2021 - PrelimsInquisito-AIIMS Medicine Quiz 2021 - Prelims
Inquisito-AIIMS Medicine Quiz 2021 - Prelims
AakanshaKumari4
Ā 
Shunt quantification and reversibility
Shunt quantification and reversibilityShunt quantification and reversibility
Shunt quantification and reversibility
GOPAL GHOSH
Ā 
Chemo rt in nsclc 2011- jk
Chemo rt in nsclc 2011- jkChemo rt in nsclc 2011- jk
Chemo rt in nsclc 2011- jk
John Lucas
Ā 
Up and Coming in the EM World
Up and Coming in the EM WorldUp and Coming in the EM World
Up and Coming in the EM World
emchatter
Ā 
Mock test for imm radiology DR. Muhammad BIn Zulfiqar
Mock test for imm radiology DR. Muhammad BIn ZulfiqarMock test for imm radiology DR. Muhammad BIn Zulfiqar
Mock test for imm radiology DR. Muhammad BIn Zulfiqar
Dr. Muhammad Bin Zulfiqar
Ā 
Nett trial
Nett trialNett trial
Nett trial
FIRAS ALJANADI
Ā 
Minimal invasive cabg
Minimal invasive cabgMinimal invasive cabg
Minimal invasive cabg
Deep Chandh
Ā 

Similar to Nuke Qa Case Review 2010 Ppt (20)

Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Important Trials of the Day & Basics of Biostatistics | IACTS SCORE 2020
Ā 
Localised carcinoma prostate.pptx
Localised carcinoma prostate.pptxLocalised carcinoma prostate.pptx
Localised carcinoma prostate.pptx
Ā 
Us The Surgeon New Best Companion
Us The Surgeon New Best CompanionUs The Surgeon New Best Companion
Us The Surgeon New Best Companion
Ā 
Management of sepsis.
Management of sepsis.Management of sepsis.
Management of sepsis.
Ā 
Electrodiagnosis of GBS
Electrodiagnosis of GBSElectrodiagnosis of GBS
Electrodiagnosis of GBS
Ā 
RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)
RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)
RADIOTHERAPY IN CARCINOMA BREAST (EARLY AND LOCALLY ADVANCED)
Ā 
Principles of nuclear cardiology
Principles of nuclear cardiologyPrinciples of nuclear cardiology
Principles of nuclear cardiology
Ā 
MANAGEMENT OF TRAUMA
MANAGEMENT OF TRAUMAMANAGEMENT OF TRAUMA
MANAGEMENT OF TRAUMA
Ā 
Shoulder advances 2015
Shoulder advances  2015Shoulder advances  2015
Shoulder advances 2015
Ā 
Inflammatory arthritis; a quick run through.
Inflammatory arthritis; a quick run through.Inflammatory arthritis; a quick run through.
Inflammatory arthritis; a quick run through.
Ā 
ACS:STEMI
ACS:STEMIACS:STEMI
ACS:STEMI
Ā 
Contrast nephropahthy
Contrast nephropahthyContrast nephropahthy
Contrast nephropahthy
Ā 
ANA Negative Lupus
ANA Negative Lupus ANA Negative Lupus
ANA Negative Lupus
Ā 
Inquisito-AIIMS Medicine Quiz 2021 - Prelims
Inquisito-AIIMS Medicine Quiz 2021 - PrelimsInquisito-AIIMS Medicine Quiz 2021 - Prelims
Inquisito-AIIMS Medicine Quiz 2021 - Prelims
Ā 
Shunt quantification and reversibility
Shunt quantification and reversibilityShunt quantification and reversibility
Shunt quantification and reversibility
Ā 
Chemo rt in nsclc 2011- jk
Chemo rt in nsclc 2011- jkChemo rt in nsclc 2011- jk
Chemo rt in nsclc 2011- jk
Ā 
Up and Coming in the EM World
Up and Coming in the EM WorldUp and Coming in the EM World
Up and Coming in the EM World
Ā 
Mock test for imm radiology DR. Muhammad BIn Zulfiqar
Mock test for imm radiology DR. Muhammad BIn ZulfiqarMock test for imm radiology DR. Muhammad BIn Zulfiqar
Mock test for imm radiology DR. Muhammad BIn Zulfiqar
Ā 
Nett trial
Nett trialNett trial
Nett trial
Ā 
Minimal invasive cabg
Minimal invasive cabgMinimal invasive cabg
Minimal invasive cabg
Ā 

Recently uploaded

Main news related to the CCS TSI 2023 (2023/1695)
Main news related to the CCS TSI 2023 (2023/1695)Main news related to the CCS TSI 2023 (2023/1695)
Main news related to the CCS TSI 2023 (2023/1695)
Jakub Marek
Ā 
PoznanĢ ACE event - 19.06.2024 Team 24 Wrapup slidedeck
PoznanĢ ACE event - 19.06.2024 Team 24 Wrapup slidedeckPoznanĢ ACE event - 19.06.2024 Team 24 Wrapup slidedeck
PoznanĢ ACE event - 19.06.2024 Team 24 Wrapup slidedeck
FilipTomaszewski5
Ā 
How to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdf
How to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdfHow to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdf
How to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdf
Chart Kalyan
Ā 
"Frontline Battles with DDoS: Best practices and Lessons Learned", Igor Ivaniuk
"Frontline Battles with DDoS: Best practices and Lessons Learned",  Igor Ivaniuk"Frontline Battles with DDoS: Best practices and Lessons Learned",  Igor Ivaniuk
"Frontline Battles with DDoS: Best practices and Lessons Learned", Igor Ivaniuk
Fwdays
Ā 
ā€œTemporal Event Neural Networks: A More Efficient Alternative to the Transfor...
ā€œTemporal Event Neural Networks: A More Efficient Alternative to the Transfor...ā€œTemporal Event Neural Networks: A More Efficient Alternative to the Transfor...
ā€œTemporal Event Neural Networks: A More Efficient Alternative to the Transfor...
Edge AI and Vision Alliance
Ā 
LF Energy Webinar: Carbon Data Specifications: Mechanisms to Improve Data Acc...
LF Energy Webinar: Carbon Data Specifications: Mechanisms to Improve Data Acc...LF Energy Webinar: Carbon Data Specifications: Mechanisms to Improve Data Acc...
LF Energy Webinar: Carbon Data Specifications: Mechanisms to Improve Data Acc...
DanBrown980551
Ā 
Dandelion Hashtable: beyond billion requests per second on a commodity server
Dandelion Hashtable: beyond billion requests per second on a commodity serverDandelion Hashtable: beyond billion requests per second on a commodity server
Dandelion Hashtable: beyond billion requests per second on a commodity server
Antonios Katsarakis
Ā 
A Deep Dive into ScyllaDB's Architecture
A Deep Dive into ScyllaDB's ArchitectureA Deep Dive into ScyllaDB's Architecture
A Deep Dive into ScyllaDB's Architecture
ScyllaDB
Ā 
Principle of conventional tomography-Bibash Shahi ppt..pptx
Principle of conventional tomography-Bibash Shahi ppt..pptxPrinciple of conventional tomography-Bibash Shahi ppt..pptx
Principle of conventional tomography-Bibash Shahi ppt..pptx
BibashShahi
Ā 
Essentials of Automations: Exploring Attributes & Automation Parameters
Essentials of Automations: Exploring Attributes & Automation ParametersEssentials of Automations: Exploring Attributes & Automation Parameters
Essentials of Automations: Exploring Attributes & Automation Parameters
Safe Software
Ā 
AppSec PNW: Android and iOS Application Security with MobSF
AppSec PNW: Android and iOS Application Security with MobSFAppSec PNW: Android and iOS Application Security with MobSF
AppSec PNW: Android and iOS Application Security with MobSF
Ajin Abraham
Ā 
Freshworks Rethinks NoSQL for Rapid Scaling & Cost-Efficiency
Freshworks Rethinks NoSQL for Rapid Scaling & Cost-EfficiencyFreshworks Rethinks NoSQL for Rapid Scaling & Cost-Efficiency
Freshworks Rethinks NoSQL for Rapid Scaling & Cost-Efficiency
ScyllaDB
Ā 
High performance Serverless Java on AWS- GoTo Amsterdam 2024
High performance Serverless Java on AWS- GoTo Amsterdam 2024High performance Serverless Java on AWS- GoTo Amsterdam 2024
High performance Serverless Java on AWS- GoTo Amsterdam 2024
Vadym Kazulkin
Ā 
Session 1 - Intro to Robotic Process Automation.pdf
Session 1 - Intro to Robotic Process Automation.pdfSession 1 - Intro to Robotic Process Automation.pdf
Session 1 - Intro to Robotic Process Automation.pdf
UiPathCommunity
Ā 
Day 2 - Intro to UiPath Studio Fundamentals
Day 2 - Intro to UiPath Studio FundamentalsDay 2 - Intro to UiPath Studio Fundamentals
Day 2 - Intro to UiPath Studio Fundamentals
UiPathCommunity
Ā 
From Natural Language to Structured Solr Queries using LLMs
From Natural Language to Structured Solr Queries using LLMsFrom Natural Language to Structured Solr Queries using LLMs
From Natural Language to Structured Solr Queries using LLMs
Sease
Ā 
Mutation Testing for Task-Oriented Chatbots
Mutation Testing for Task-Oriented ChatbotsMutation Testing for Task-Oriented Chatbots
Mutation Testing for Task-Oriented Chatbots
Pablo GĆ³mez Abajo
Ā 
Demystifying Knowledge Management through Storytelling
Demystifying Knowledge Management through StorytellingDemystifying Knowledge Management through Storytelling
Demystifying Knowledge Management through Storytelling
Enterprise Knowledge
Ā 
"$10 thousand per minute of downtime: architecture, queues, streaming and fin...
"$10 thousand per minute of downtime: architecture, queues, streaming and fin..."$10 thousand per minute of downtime: architecture, queues, streaming and fin...
"$10 thousand per minute of downtime: architecture, queues, streaming and fin...
Fwdays
Ā 
JavaLand 2024: Application Development Green Masterplan
JavaLand 2024: Application Development Green MasterplanJavaLand 2024: Application Development Green Masterplan
JavaLand 2024: Application Development Green Masterplan
Miro Wengner
Ā 

Recently uploaded (20)

Main news related to the CCS TSI 2023 (2023/1695)
Main news related to the CCS TSI 2023 (2023/1695)Main news related to the CCS TSI 2023 (2023/1695)
Main news related to the CCS TSI 2023 (2023/1695)
Ā 
PoznanĢ ACE event - 19.06.2024 Team 24 Wrapup slidedeck
PoznanĢ ACE event - 19.06.2024 Team 24 Wrapup slidedeckPoznanĢ ACE event - 19.06.2024 Team 24 Wrapup slidedeck
PoznanĢ ACE event - 19.06.2024 Team 24 Wrapup slidedeck
Ā 
How to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdf
How to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdfHow to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdf
How to Interpret Trends in the Kalyan Rajdhani Mix Chart.pdf
Ā 
"Frontline Battles with DDoS: Best practices and Lessons Learned", Igor Ivaniuk
"Frontline Battles with DDoS: Best practices and Lessons Learned",  Igor Ivaniuk"Frontline Battles with DDoS: Best practices and Lessons Learned",  Igor Ivaniuk
"Frontline Battles with DDoS: Best practices and Lessons Learned", Igor Ivaniuk
Ā 
ā€œTemporal Event Neural Networks: A More Efficient Alternative to the Transfor...
ā€œTemporal Event Neural Networks: A More Efficient Alternative to the Transfor...ā€œTemporal Event Neural Networks: A More Efficient Alternative to the Transfor...
ā€œTemporal Event Neural Networks: A More Efficient Alternative to the Transfor...
Ā 
LF Energy Webinar: Carbon Data Specifications: Mechanisms to Improve Data Acc...
LF Energy Webinar: Carbon Data Specifications: Mechanisms to Improve Data Acc...LF Energy Webinar: Carbon Data Specifications: Mechanisms to Improve Data Acc...
LF Energy Webinar: Carbon Data Specifications: Mechanisms to Improve Data Acc...
Ā 
Dandelion Hashtable: beyond billion requests per second on a commodity server
Dandelion Hashtable: beyond billion requests per second on a commodity serverDandelion Hashtable: beyond billion requests per second on a commodity server
Dandelion Hashtable: beyond billion requests per second on a commodity server
Ā 
A Deep Dive into ScyllaDB's Architecture
A Deep Dive into ScyllaDB's ArchitectureA Deep Dive into ScyllaDB's Architecture
A Deep Dive into ScyllaDB's Architecture
Ā 
Principle of conventional tomography-Bibash Shahi ppt..pptx
Principle of conventional tomography-Bibash Shahi ppt..pptxPrinciple of conventional tomography-Bibash Shahi ppt..pptx
Principle of conventional tomography-Bibash Shahi ppt..pptx
Ā 
Essentials of Automations: Exploring Attributes & Automation Parameters
Essentials of Automations: Exploring Attributes & Automation ParametersEssentials of Automations: Exploring Attributes & Automation Parameters
Essentials of Automations: Exploring Attributes & Automation Parameters
Ā 
AppSec PNW: Android and iOS Application Security with MobSF
AppSec PNW: Android and iOS Application Security with MobSFAppSec PNW: Android and iOS Application Security with MobSF
AppSec PNW: Android and iOS Application Security with MobSF
Ā 
Freshworks Rethinks NoSQL for Rapid Scaling & Cost-Efficiency
Freshworks Rethinks NoSQL for Rapid Scaling & Cost-EfficiencyFreshworks Rethinks NoSQL for Rapid Scaling & Cost-Efficiency
Freshworks Rethinks NoSQL for Rapid Scaling & Cost-Efficiency
Ā 
High performance Serverless Java on AWS- GoTo Amsterdam 2024
High performance Serverless Java on AWS- GoTo Amsterdam 2024High performance Serverless Java on AWS- GoTo Amsterdam 2024
High performance Serverless Java on AWS- GoTo Amsterdam 2024
Ā 
Session 1 - Intro to Robotic Process Automation.pdf
Session 1 - Intro to Robotic Process Automation.pdfSession 1 - Intro to Robotic Process Automation.pdf
Session 1 - Intro to Robotic Process Automation.pdf
Ā 
Day 2 - Intro to UiPath Studio Fundamentals
Day 2 - Intro to UiPath Studio FundamentalsDay 2 - Intro to UiPath Studio Fundamentals
Day 2 - Intro to UiPath Studio Fundamentals
Ā 
From Natural Language to Structured Solr Queries using LLMs
From Natural Language to Structured Solr Queries using LLMsFrom Natural Language to Structured Solr Queries using LLMs
From Natural Language to Structured Solr Queries using LLMs
Ā 
Mutation Testing for Task-Oriented Chatbots
Mutation Testing for Task-Oriented ChatbotsMutation Testing for Task-Oriented Chatbots
Mutation Testing for Task-Oriented Chatbots
Ā 
Demystifying Knowledge Management through Storytelling
Demystifying Knowledge Management through StorytellingDemystifying Knowledge Management through Storytelling
Demystifying Knowledge Management through Storytelling
Ā 
"$10 thousand per minute of downtime: architecture, queues, streaming and fin...
"$10 thousand per minute of downtime: architecture, queues, streaming and fin..."$10 thousand per minute of downtime: architecture, queues, streaming and fin...
"$10 thousand per minute of downtime: architecture, queues, streaming and fin...
Ā 
JavaLand 2024: Application Development Green Masterplan
JavaLand 2024: Application Development Green MasterplanJavaLand 2024: Application Development Green Masterplan
JavaLand 2024: Application Development Green Masterplan
Ā 

Nuke Qa Case Review 2010 Ppt

  • 1. Nuclear QA: Case Review Darcy Conaway January 2010
  • 2. OUTLINE ā€¢ CASES FROM AUGUST, SEPTEMBER, AND OCTOBER 2009 ā€¢ TRENDS ā€¢ DISCUSSION OF WAYS TO IMPROVE REPORTING
  • 3. About Nuclear QA ā€¢ Keepcath of all patients that had a nuclear followed by a log within a year ā€¢ Do the ļ¬ndings correlate? ā€¢ COMPLETE AGREEMENT ā€¢ GENERAL AGREEMENT ā€¢ MINOR DISCORDANCE ā€¢ MAJOR DISCORDANCE
  • 4. Nuke QA Started in 2008 ā€¢ Initial problems primarily due to very high false positive rate causing high major discordance rates ā€¢ We initiated prone imaging, using regadenoson, became diligent with patient selection (ex: 2-day studies for elevated BMI) and adopted the ASNC recommended method for reporting ā€¢ 2009 trends showed improvement
  • 5. **Signiļ¬cant percentages of major discordances when comparing nuclear to cardiac catheterization --July 2008: 5 major discordances (71%) 7 total for correlation --August 2008: 1 major discordance (20%) 5 total for correlation --September 2008: 3 major discordances (50%) 6 total for correlation
  • 6. -cont. October 2008: 5 major discordances (36%) 14 total for correlation November 2008: No major discordances (0%) 14 total for correlation December 2008: 1 major discordance (17%) 6 total for correlation
  • 7. Trends January 2009-May 2009 ā€¢ January 2009: No major discordances (4 total for correlationļƒ 0% ā€¢ February 2009: 2 major discordances (8 total for review; 1 of these was deemed appropriately read and due to quality of imaging by case review)ļƒ 13% ā€¢ March 2009: No nuclear/cath for correlation ā€¢ April 2009: 0 major discordance (5 total for reviewļƒ 0%) ā€¢ May 2009: 1 major discordance that is due to patchy uptake in a cardiomyopathy patient (4 total for correlation) ā€¢ June 2009: No major discordances ā€¢ July 2009: 1/6 major discordance (17%)
  • 8. Trends and Case Review 8/09-10/09 ā€¢ AUGUST 2009: 78 total nukes done ā€¢ 3 for correlation with cath ā€¢ 1 major discordanceā€¦.WOULD LIKE INPUT AS TO WHETHER OR NOT THIS IS A MAJOR DISCORDANCE
  • 9. ā€¢ MPI 2/3/09 CASE 1 ā€¢ CATH 8/28/09 ā€¢ 1-DAY STUDY ā€¢ REGADENOSON ā€¢ PRONE USED AS AN ADJUNCT ā€¢ ECG NEGATIVE ā€¢ POST STRESS IMAGING 45 MINUTES AFTER INJECTION
  • 10. SHORT AXIS SUPINE SHORT AXIS PRONE
  • 11. LONG AXIS SUPINE LONG AXIS PRONE
  • 14. MPI IMPRESSION ā€¢ NEGATIVE ECG FOR ISCHEMIA ā€¢ NORMAL EF ā€¢ NORMAL PERFUSION
  • 15. CATH ā€¢ LM normal ā€¢ LAD 40% proximal, 40-50% mid to distal ā€¢ diag 2 30% ā€¢ LCx 70% distally, small artery ā€¢ RCA (dominant) subtotal occlusion proximal with left to right collaterals ā€¢ unsuccessful angioplasty; small self contained coronary perforation
  • 16. NUKE MISREAD OR MISSED ISCHEMIA? ā€¢ LABELLED AS A FALSE NEGATIVE BUT I THINK THIS IS LIKELY A MINOR DISCORDANCE ā€¢ DISTAL LCX IS SMALL; MAY BE MILDLY ISCHEMIC BUT THE QUALITY OF THE REST IMAGES ARE PROBLEMATIC IN READING THIS STUDY ACCURATELY ā€¢ COLLATERALS TO THE RCA WOULD PREVENT IT FROM BEING ISCHEMIC AND ECG WAS NEGATIVE ā€¢ ONE POINT: SHOULD ATTEMPT PRONE OF REST WHEN DEFECT PRESENT ā€¢ CONCERN: DID WE PERFORM PROCEDURE CORRECTLY/I.E. MAXIMAL HYPEREMIA WITH REGADENOSON? ECG NEGATIVE ... FALSE NEGATIVE? MINOR DISCORDANCE? NOT GETTING MAXIMAL HYPEREMIA WITH REGADENOSON?
  • 17. CORRELATION ā€¢ SEPTEMBER (N=85) ā€¢ 12 FOR CORRELATION; 1 EXCLUDED DUE TO BEING >1 YEAR FROM NUKE TO CATH ā€¢ 1 MAJOR DISCORDANCE THAT WAS LIKELY BALANCED ISCHEMIA (ā€˜ACCEPTABLE FALSE NEGATIVEā€™)
  • 18. -CONT ā€¢ OCTOBER (N=60); 11 TO CORRELATE ā€¢ 8/11 WERE CA OR GA ā€¢ 13 TOTAL: 1 NON-DIAGNOSTIC, 1 EXCLUDED DUE TO BEING JUST AT A YEAR OUT FROM CATH ā€¢ 2 MINOR DISCORDANCES ā€¢ 1 UNKNOWN: MPI NO ISCHEMIA; CATH WITH LAD BRIDGING. GENERAL AGREE?
  • 19. CASE 2: SHORT AXIS SUPINE ā€¢ MPI 8/4/09 ā€¢ ONE DAY STUDY ā€¢ REGADENOSON ā€¢ PRONE USED AS AN ADJUNCT ā€¢ NEGATIVE ECG ā€¢ STRESS IMAGING 48MIN AFTER ISOTOPE ā€¢ REST IMAGING 45 MIN AFTER
  • 20. SHORT AXIS SUPINE SHORT AXIS PRONE
  • 21. LONG AXIS SUPINE LONG AXIS PRONE
  • 22.
  • 23. MPI IMPRESSION ā€¢ MILDLY ABNORMAL (SSS6) WITH FIXED INFERIOR/INFEROLATERAL DEFECT ā€¢ QUALITY:FAIR ā€¢ EF NORMAL WITH MILD INFERIOR/ INFEROLATERAL HYPOKINESIS
  • 24. CATH ā€¢ LM normal ā€¢ LAD ostial 60% ā€¢ LCx free of disease ā€¢ RCA free of disease ā€¢ Ramus free of disease CASE OF SIGNIFICANT ARTIFACT THAT LED TO MISREAD PLANAR: ELEVATED LEFT MINOR HEMIDIAPHRAGM DISCORDANCE? FAIR QUALITY
  • 25. CASE 3 ā€¢ 2-DAY STUDY ā€¢ EXERCISE (6:32) ā€¢ MALE PT ā€¢ STRESS IMAGING 2 HOURS AFTER INJECTION; REST IMAGING 40 MINUTES AFTER INJECTION
  • 26. SHORT AXIS SUPINE SHORT AXIS PRONE
  • 27. LONG AXIS SUPINE LONG AXIS PRONE
  • 30. MPI IMPRESSION ā€¢ MILDLY ABNORMAL; SUGGESTIVE OF BRANCH VESSEL LAD DISEASE (DIAGONAL) ā€¢ TECHNICAL ISSUES WITH GATING SO NO EF GIVEN
  • 31. CATH ā€¢ NORMAL CORONARIES ā€¢ MPI PLANAR WITH MILD BREAST ATTENUATION, LATERAL WALL FAT AND MILD VERTICAL MOTION MINOR DISCORDANCE? MORE SIGNIFICANT?
  • 32. CASE 4 ā€¢ 1-DAY STUDY ā€¢ REGADENOSON ā€¢ PRONE USED AS AN ADJUNCT ā€¢ REST: 1HR AND 15 MIN AFTER INJECTION ā€¢ STRESS:1 HOUR AND 5 MINUTES AFTER
  • 33. SHORT AXIS SUPINE SHORT AXIS PRONE
  • 34. LONG AXIS SUPINE LONG AXIS PRONE
  • 36. MPI IMPRESSION ā€¢ OCCLUDED LCX AND/OR RCA BRANCH VESSEL AT BASE WITHOUT ISCHEMIA ā€¢ LOW RISK ā€¢ MILDLY REDUCED EF
  • 37. CATH ā€¢ NON OBSTRUCTIVE CAD THIS IS DOWN AS A GENERAL AGREEMENT SINCE IT WAS READ AS LOW RISK; CHANGE TO DISCORDANCE?
  • 38. NEXT CASE ā€¢ 45 Y/O MALE WITH KNOWN CAD/PRIOR MI ā€¢ EXERCISE STUDY (7:46) ā€¢ ECG WITH T WAVE INVERSION AT BASELINE INFEROLATERALLY; PSEUDONORMALIZATION DURING STRESS ā€¢ 1-DAY STUDY WITH PRONE AS ADJUNCT
  • 39. CASE 5 SUPINE PRONE
  • 40.
  • 41.
  • 42. MPI IMPRESSION ā€¢ ABNORMAL WITH LARGE FIXED INFERIOR DEFECT AND MODERATE FIXED ANTERIOR DEFECT ā€¢ DO YOU AGREE ? THOUGHTS.... ā€¢ NORMAL EF ā€¢ POOR QUALITY ā€¢ Prior nuke in 2003 with large defect, also non-
  • 43. CATH-the plot thickens ā€¢ The one we correlated with was 10/09: ā€¢ No signiļ¬cant CAD; mid-distal focal area of myocardial bridging LAD ā€¢ Prior cath in 2005: ā€¢ 90% proximal ramus intermedius ā€¢ 50-60% proximal rca SO IS THIS THE WRONG CATH?
  • 44. NEXT CASE: GOOD CORRELATION DESPITE ATTENUATION ā€¢ 39 Y/O FEMALE ā€¢ 2-DAY STUDY DUE TO BMI ā€¢ REGADENOSON (??) ā€¢ SEVERE BREAST ATTENUATION ā€¢ PRONE USED AS ADJUNCT ā€¢ SHOULD WE HAVE DONE NUKE?
  • 45. CASE 6 SHORT AXIS SHORT AXIS SUPINE PRONE
  • 46. LONG AXIS LONG AXIS PRONE SUPINE
  • 48. MPI IMPRESSION ā€¢ POOR QUALITY: SEVERE BREAST ATTENUATION ā€¢ MODERATE AREA OF INFARCTION INFERIOR AND INFEROLATERALLY SUGGESTING RCA AND/OR LCX DISEASE ā€¢ NORMAL EF
  • 49. CATH ā€¢ TWO VESSEL CAD ā€¢ RCA MID 90%, MID-DISTAL 70% ā€¢ MID LAD 60% (NEGATIVE FFR OF LAD)
  • 50. NEXT CASE ā€¢ 56Y/O MALE WITH PPM ā€¢ REGADENOSON ā€¢ 1-DAY STUDY WITH PRONE AS ADJUNCT
  • 51. SHORT AXIS SUPINE SHORT AXIS PRONE
  • 53. MPI IMPRESSION AND CATH ā€¢ MPI: RCA OR LCX INFARCTION WITH MINIMAL RESIDUAL ISCHEMIA ; LOW RISK ā€¢ CATH: 3 VESSEL CAD ā€¢ 70-80% PROX LAD, 99% OSTIAL LCX, 80% MID RCA LIKELY A CASE OF BALANCED ISCHEMIA WITH TIGHTER LCX SO ONLY ONE DISTRIBUTION DEMONSTRATED ISCHEMIA; MAJOR DISCORDANCE THAT IS ā€œACCEPTABLE?ā€
  • 54. NEXT CASE ā€¢ 58Y/O FEMALE ā€¢ EXERCISE STUDY (6:20) ā€¢ 1-STUDY STUDY ā€¢ PLANAR FINDINGS NOT MENTIONED- QUALITY LISTED AS FAIR (LIKELY BREAST ATTENUATION) ā€¢ PRONE USED AS ADJUNCT
  • 55. SHORT AXIS SUPINE SHORT AXIS PRONE
  • 57. CORRELATION ā€¢ MPI: ABNORMAL; POSITIVE FOR ISCHEMIA ā€¢ NO MENTION OF RISK OF STUDY ā€¢ ANTERIOR DEFECT FELT TO BE DUE TO BREAST; MODERATE REVERSIBLE DEFECT APICALLY AND LATERALLY ā€¢ CATH: LAD PCI; MILD TO MODERATE LCX (NO PERCENTAGE GIVEN), PLV OSTIUM (SMALL VESSEL) WITH 90% FOCAL STENOSIS FOR QA: GENERAL AGREE? SOME COMMENT SHOULD BE MADE THAT NUKE NOT GOOD FOR THIS PT IN THE FUTURE DUE TO SEVERITY OF BREAST ATTENUATION? PLACE IT INTO NON- DIAGNOSTIC FOR LAD TERRITORY?
  • 58. NOVEMBER/DECEMBER ā€¢ HIGH NUMBERS OF POOR QUALITY STUDIES ā€¢ NOVEMBER: (N=80);14 FOR CORRELATION ā€¢ 7/14 WERE IN GENERAL OR COMPLETE AGREEMENT ā€¢ 2 MINOR DISCORDANCE-->PLANAR FINDINGS NOT DESCRIBED ON EITHER OF THESE ā€¢ 3 MAJOR DISCORDANCE--> 1 LIKELY BALANCED ISCHEMIA (ā€˜ACCEPTABLEā€™ MAJOR DISCORDANCE); ANOTHER DESCRIBED AS POOR QUALITY BUT NOT READ AS NON-DIAGNOSTIC; OTHER NEEDS REVIEW ā€¢ 1 NON-DIAGNOSTIC DUE TO BREAST ATTENUATION ā€¢ ISSUE: IF POOR QUALITY STUDY WE SHOULD STATE WHY IN PLANAR SECTION AND READ STUDY AS NON-DIAGNOSTIC
  • 59. ā€¢ DECEMBER (N=59); 14 FOR CORRELATION ā€¢ 7/14 CA OR GA ā€¢ I MINOR DISCORDANCE ā€¢ 2 MAJOR DISCORDANCE; 1 DOCUMENTED AS POOR QUALITY STUDY ā€¢ 1 READ AS NON-DIAGNOSTIC DUE TO BREAST, 1 READ AS EQUIVOCAL DUE TO SEVERE VERTICAL MOTION, 1 TECHNICAL ISSUE (FAIR
  • 60. REPORTING ISSUES ā€¢ MANY STUDIES WITHOUT MENTION OF PLANAR IMAGING FINDINGS ā€¢ NEED TO STATE IF PRONE WAS OR WAS NOT PERFORMED ā€¢ MUST HAVE CORONARY ARTERY DISTRIBUTION FOR DEFECTS--MANY STUDIES REPORTED ONLY AS ISCHEMIC WITHOUT MENTION OF DISTRIBUTION OR SEVERITY OF RISK (MILD/ MOD/SEVERE)
  • 61. REVIEW ā€¢ OVERALL TREND FOR 2009 WAS SIGNIFICANT IMPROVEMENT ā€¢ THE LAST TWO MONTHS THERE WERE INCREASED NUMBERS OF POOR QUALITY IMAGES (PT SELECTION?) ā€¢ PHYSICIAN REPORTS: LACKING PLANAR IMAGING FINDINGS AND CONSISTENCY IN TERMS OF STATING RISK
  • 62. REMINDER: ASNC GUIDELINES FOR REPORTING ā€¢ REQUIRED: PERFUSION DEFECT LOCATION, SEVERITY, AND SIZE ā€¢ SEVERITY= MILD,MODERATE,SEVERE ā€¢ SMALL= 1-2 SEGMENTS ā€¢ MEDIUM=3-4 SEGMENTS ā€¢ LARGE= 5 OR MORE SEGMENTS ā€¢ TID IS REQUIRED
  • 63. TO THINK ABOUT... ā€¢ MANY EXPERTS BELIEVE THAT AC IMAGING CAN INCREASE THE NUMBER OF STRESS ONLY IMAGES (GETTING ASKED MORE FREQUENTLY TO DO THIS WHEN POSSIBLE ON IN-PTS) ā€¢ REMINDER: THIS IS APPLICABLE MAINLY TO PTS WHO EXERCISE ā€¢ PHARMACOLOGIC NORMALS HAVE SIGNIFICANTLY HIGHER RATE OF CARDIAC EVENTS WITHIN THE NEXT YEAR AS COMPARED TO NORMALS WHO DID BRUCE